Free Trial
→ The centerpiece of Trump’s crypto’s masterplan … (From Weiss Ratings) (Ad) Free NTLA Stock Alerts

Intellia Therapeutics (NTLA) ESG Score & Sustainability Data

Intellia Therapeutics logo
$15.24
+0.10 (+0.66%)
(As of 03:39 PM ET)
Compare

Key ESG Takeaways for Intellia Therapeutics

The key takeaways are AI-generated and highlight the main contributors behind the net impact scores of Intellia Therapeutics. The insights are based on millions of scientific articles, along with the company-specific product and service portfolio.
  • Intellia Therapeutics seems to create the most significant positive value in categories , , and . The largest positive contribution comes from its impact, which is false driven by its Preclinical research services for physical health, Clinical research services for genetic diseases, and Basic medical research services for physical health products.
  • On the other hand, these positive outcomes are achieved by using resources or causing negative impacts in categories , , and . The negative contribution in the impact category is driven by its Clinical research services for genetic diseases, Preclinical research services for physical health, and Basic medical research services for physical health products.
  • To improve its net impact, a company can either grow its positive impacts, or reduce its negative impacts. For example, by doubling its Preclinical research services for physical health business, Intellia Therapeutics would improve its net impact ratio by 1 percentage points.

NTLA Impact Ratio

Net impact ratio represents the net impact of a company. It is defined as the (positive impacts - negative impacts) / positive impacts. The maximum value for net impact ratio is 100%, representing a theoretical company with no negative impacts. The minimum value is -∞. Net scores depend on the value sets that determine the importance of different impact categories.
+74.6%
The default value set, where each category is given the same weight.

Value Sets Value sets can be used to assess how different stakeholder values or emphasis on certain values might affect the net impact ratio.

Millennials
Value set of millennials (b. 1980 - 1999), based on Upright's annual Impact at Work survey.
+78.8%
Most Wanted Workforce
Value set of the most wanted workforce, based on Upright's annual Impact at Work survey.
+72.5%
Society First
Value set that emphasizes society impacts over other impacts.
+59.5%
Knowledge First
Value set that emphasizes knowledge impacts over other impacts.
+91.6%
Health First
Value set that emphasizes health impacts over other impacts.
+81.7%

Intellia Therapeutics ESG Score + Net Impact Profile

ImpactNegativeScorePositive
+1.98
+1.98
+1.94
+1.94
+0.00
+0.00
-0.01
+0.01
+0.02
-0.08
+0.14
+0.22
0.00
+0.00
+6.18
+6.18
-0.00
0.00
+0.00
-2.35
-2.35
-0.36
+2.43
+2.78
-0.02
+0.42
+0.44
0.00
+0.00
-0.00
+0.00
+0.00
-0.00
+0.15
+0.15
-0.21
-0.21
+0.00
-0.04
-0.04
+0.00
-0.04
-0.04
+0.00
-0.04
-0.04
+0.00
-0.34
-0.34
+0.00

Upright Model Version 0.4.0
ESG Data Last Updated: April 1, 2022

Ad Darwin
Unlock the Secret to Earning Consistent Income from Stocks Under $30!
Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE!
👉 Yes, I Want the Free Report! 👈

About Upright's Net Impact Model

Upright Model

Upright's Net Impact Data quantifies the holistic value creation and impact of companies. It details both the negative and positive impacts a company has on the environment, health of people, society and knowledge, and forms a net sum of these costs and gains based on the economic costs of each impact category. The data is produced by Upright's Net Impact model, which is a mathematical model of the economy that produces continuously updated estimates of the net impact of companies by means of an information integration algorithm. The data is primarily sourced from the CORE open access database, which contains over 200 million scientific papers. Other sources of data include open databases published by the World Bank, IMF, WHO, OECD, IPCC, CDC and USDA.

Intellia Therapeutics ESG Score - Frequently Asked Questions

How is Intellia Therapeutics doing in terms of sustainability?

According to The Upright Project, which measures holistic value creation and impact of companies, Intellia Therapeutics has a net impact ratio of 74.6%, indicating an overall positive sustainability impact. Intellia Therapeutics seems to create the most significant positive value in the categories of Creating knowledge, Physical diseases, and Jobs. On the other hand, these positive outcomes are achieved by using resources or causing negative impacts in the categories of Scarce human capital, Physical diseases, and Waste. Learn more on the sustainability of Intellia Therapeutics.


More ESG Stocks and Research Tools

Related Companies
Stock Lists
Sustainability Tools

This page (NASDAQ:NTLA) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners
Bill Gates’s Next Big AI Bet: Stargate
In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...
Brownstone Research | Sponsored
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
The pin that pops the AI bubble
My new documentary explores the background to this pattern and how and why I believe it will almost certainly ...
Porter & Company | Sponsored
626 winning trades out of 647…
Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...
Investing Daily | Sponsored
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...
Crypto Swap Profits | Sponsored
Is Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...
Paradigm Press | Sponsored
NASDAQ small cap that could be gearing up for a massive short squeeze.
A Heavy Short Interest Could Lead to a Monstrous Short Squeeze for this Tiny NASDAQ Healthcare Firm!
Huge Alerts | Sponsored
WARNING: “Buffett Indicator” flashing for first time in 50 years
Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...
Behind the Markets | Sponsored